Skip to content

Risk factor for hepatic fibrosis in men with type 2 diabetes

Risk factor for hepatic fibrosis in men with type 2 diabetes - Risk factor for hepatic fibrosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000021519
Enrollment
193
Registered
2016-03-17
Start date
2016-03-17
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabetes mellitus

Interventions

None listed

Sponsors

Uwajima City Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: men with type 2 diabetes

Exclusion criteria

Exclusion criteria: 1.type 1 diabetes or other type diabetes 2.more than 20g/day of alcohol consumption 3.positive for HBsAg or anti-HCV 4.patient with any other liver disease, such as other viral hepatitis, autoimmune hepatitis, or primary biliary cirrhosis

Design outcomes

Primary

MeasureTime frame
Identify the risk factor for a hepatic fibrosis index calculated with results of examination on admission for diabetes treatment

Countries

Japan

Contacts

Public ContactShozo Miyauchi

Uwajima City Hospital Department of Internal Medicine

syozo@uwajima-mh.jp0895251111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026